The DOI matches its Crossref record; 298 of the 298 references it cites were found in a registry or an index.
Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Open accessAbstract
During the past decade, a conceptual shift occurred in the field of Alzheimer's disease (AD) considering the disease as a continuum. Thanks to evolving biomarker research and substantial discoveries, it is now possible to identify the disease even at the preclinical stage before the occurrence of the first clinical symptoms. This preclinical stage of AD has become a major research focus as the field postulates that early intervention may offer the best chance of therapeutic success. To date, very little evidence is established on this “silent” stage of the disease. A clarification is needed about the definitions and lexicon, the limits, the natural history, the markers of progression, and the ethical consequence of detecting the disease at this asymptomatic stage. This article is aimed at addressing all the different issues by providing for each of them an updated review of the literature and evidence, with practical recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This could explain why part of the risk factors for cardiovascular disease are in common with AD, including hypertension, dyslipidemia, diabetes, obesity, dietary factors, smoking, and physical activity (Figure 1B).”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [22]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Thus, lifestyle is also an important risk factor, where intellectual, physical, and social activities, as well as diet, may help to prevent AD [1,22,100,101,102,103].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Thus, the disease is now regarded as a continuum rather than three distinct clinically defined entities [15].”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“While differences remain, IWG 2016 and the NIA research framework are aligned on the key issue that the combination of an abnormal Aβ and tau biomarker constitutes AD regardless of cognitive symptoms, and thus AD is a biologically defined entity throughout its continuum.”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [15]
In the citing paper
“Furthermore, drug development research for AD has become more complicated as preclinical and prodromal AD populations are potentially included in current trials, as well as traditionally included populations of all the clinical stages of AD dementia.38”
From Current and Future Treatments in Alzheimer Disease: An Update (2020) · cites this paper as [38]
In the citing paper
“Although the use of clinical trial simulators is not frequent in recent research,38”
From Current and Future Treatments in Alzheimer Disease: An Update (2020) · cites this paper as [38]
In the citing paper
“This asymptomatic phase of AD (AsymAD) is currently considered a preclinical stage of the disease [27, 28].”
From Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease (2018) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“From the tau protein perspective, one study showed that alterations in CSF levels of p-tau may precede those of Ab [57], which correlates with postmortem evidence showing the presence of neurofibrillary tangles in the entorhinal cortex and in hippocampal-related structures [58,59] as the first neuropathologic event in…”
ResultCorder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationBiomarkers and surrogate endpoints: Preferred definitions and conceptual framework
Biomarkers Definitions Working Group (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,771
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Exercise training increases size of hippocampus and improves memory
Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L., Kim, J. S., Heo, S., Alves, H., White, S. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015950108 · Cited by 4,855
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Self-citationJack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Self-citationMeta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Self-citationClinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Self-citation
Cited by
Sorted by citations
Items 301–400 of 1,003
Neuroinflammation in pathogenesis of Alzheimer’s disease: Phytochemicals as potential therapeutics
Vaiserman, A. M., Koliada, A. K., & Lushchak, O. V. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111259 · Cited by 57
Jiang, M., Zhang, X., Yan, X., Mizutani, S., Kashiwazaki, H., Ni, J., & Wu, Z. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.08.213 · Cited by 61
Gomes, P., Tzouanou, F., Skolariki, K., Vamvaka-Iakovou, A., Nogueras‐Ortiz, C. J., Tsirtsaki, K., Waites, C. L., Vlamos, P., Sousa, N., Costa‐Silva, B., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114183 · Cited by 60
Hypothesis review: Alzheimer's overture guidelines
Ferrer, I. (2022) · Brain Pathology · doi:10.1111/bpa.13122 · Cited by 55
Farooqui, Z., Bakulski, K. M., Power, M. C., Weisskopf, M. G., Sparrow, D., Spiro, A., Vokonas, P., Nie, L. H., Hu, H., & Park, S. K. (2016) · Environmental Research · doi:10.1016/j.envres.2016.10.007 · Cited by 56
Lauriola, M., Esposito, R., Pizzi, S. D., de Zambotti, M., Londrillo, F., Kramer, J. H., Rabinovici, G. D., & Tartaro, A. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.11.006 · Cited by 58
Self-citationPosner, H. B., Curiel, R. E., Edgar, C. J., Hendrix, S. B., Liu, E., Loewenstein, D., Morrison, G., Shinobu, L. A., Wesnes, K. A., & Harvey, P. D. (2017) · PubMed Central · Cited by 56
Teunissen, C. E., Otto, M., Engelborghs, S., Herukka, S., Lehmann, S., Lewczuk, P., Lleó, A., Perret‐Liaudet, A., Tumani, H., Turner, M. R., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0359-x · Cited by 56
Self-citationBeauchet, O., Sekhon, H., Barden, J. M., Liu-Ambrose, T. Y. L., Chester, V. L., Szturm, T. J., Grenier, S., Léonard, G., Bherer, L., & Allali, G. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180203 · Cited by 56
Language Performance of Individuals at Risk for Mild Cognitive Impairment
McCullough, K., Bayles, K. A., & Bouldin, E. D. (2019) · Journal of Speech Language and Hearing Research · doi:10.1044/2018_jslhr-l-18-0232 · Cited by 57
The AB255 Study Group, Pérez‐Grijalba, V., Arbizu, J., Romero, J., Prieto, E., Pesini, P., Sarasa, L., Guillén, F., Monleón, I., José, I. S., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0549-1 · Cited by 60
Efeoğlu, Ç., Selcuk, Ö., Demır, B., Şahi̇n, E., Sari, H., Türkeş, C., Demir, Y., Nural, Y., & Beydemir, Ş. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.137365 · Cited by 55
Dickerson, B. C., Atri, A., Clevenger, C. K., Karlawish, J. H., Knopman, D. S., Lin, P., Norman, M., Onyike, C. U., Sano, M., Scanland, S., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14337 · Cited by 62
Self-citationThe biomarker-based diagnosis of Alzheimer's disease. 2—lessons from oncology
Boccardi, M., Gallo, V., Yasui, Y., Vineis, P., Padovani, A., Mosimann, U. P., Giannakopoulos, P., Gold, G., Dubois, B., Jack, C. R., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.01.021 · Cited by 56
Self-citationAn Algorithm for Preclinical Diagnosis of Alzheimer's Disease
Khan, T. K. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00275 · Cited by 56
Kawagoe, T., Onoda, K., & Yamaguchi, S. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101675 · Cited by 55
Ikonomović, M. D., Buckley, C. J., Abrahamson, E. E., Kofler, J., Mathis, C. A., Klunk, W. E., & Farrar, G. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02175-1 · Cited by 58
A survey of brain network analysis by electroencephalographic signals
Luo, C., Li, F., Li, P., Yi, C., Li, C., Tao, Q., Zhang, X., Si, Y., Yao, D., Yin, G., et al. (2021) · Cognitive Neurodynamics · doi:10.1007/s11571-021-09689-8 · Cited by 54
Neuronal-Derived EV Biomarkers Track Cognitive Decline in Alzheimer’s Disease
Eren, E., Leoutsakos, J., Troncoso, J. C., Lyketsos, C. G., Oh, E. S., & Kapogiannis, D. (2022) · Cells · doi:10.3390/cells11030436 · Cited by 55
Ding, M., Ding, S., Du, D., Wang, X., Hu, X., Guan, P., Lyu, Z., & Lin, Y. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117087 · Cited by 56
Sadoun, A., Rosito, M., Fonta, C., & Girard, P. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.10.003 · Cited by 53
Turriziani, P., Smirni, D., Mangano, G. R., Zappalà, G., Giustiniani, A., Cipolotti, L., & Oliveri, M. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190888 · Cited by 55
The Molecular Effects of Environmental Enrichment on Alzheimer’s Disease
Liew, A. K. Y., Teo, C. H., & Soga, T. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03016-w · Cited by 61
Cognitive and Neuropathophysiological Outcomes of Gamma-tACS in Dementia: A Systematic Review
Manippa, V., Palmisano, A., Nitsche, M. A., Filardi, M., Vilella, D., Logroscino, G., & Rivolta, D. (2023) · Neuropsychology Review · doi:10.1007/s11065-023-09589-0 · Cited by 56
Aβ seeding potency peaks in the early stages of cerebral β‐amyloidosis
Ye, L., Rasmussen, J., Kaeser, S. A., Marzesco, A., Obermüller, U., Mahler, J., Schelle, J., Odenthal, J., Krüger, C., Fritschi, S. K., et al. (2017) · EMBO Reports · doi:10.15252/embr.201744067 · Cited by 54
Hwang, J., Jeong, J. H., Yoon, S. J., Park, K. W., Kim, E., Yoon, B., Jang, J., Kim, H. J., Hong, J. Y., Lee, J., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030341 · Cited by 52
Skouras, S., Falcón, C., Tucholka, A., Rami, L., Sánchez‐Valle, R., Lladó, A., Gispert, J. D., & Molinuevo, J. L. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101777 · Cited by 53
Self-citationA method for assessing tissue respiration in anatomically defined brain regions
Underwood, E., Redell, J. B., Zhao, J., Moore, A. N., & Dash, P. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-69867-2 · Cited by 51
Diagnostic and Prognostic Role of Semantic Processing in Preclinical Alzheimer’s Disease
Venneri, A., Carta, C., Marco, M. D., Quaranta, D., & Marra, C. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0324 · Cited by 55
Biomarker-guided clustering of Alzheimer's disease clinical syndromes
Toschi, N., Lista, S., Baldacci, F., Cavedo, E., Zetterberg, H., Blennow, K., Kilimann, I., Teipel, S. J., dos Santos, A. M., Epelbaum, S., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.032 · Cited by 51
Self-citationPerformance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease
Wilson, E. N., Young, C. B., Benitez, J. A. R., Swarovski, M. S., Feinstein, I., Vandijck, M. L. J., Guen, Y. L., Kasireddy, N. M., Shahid, M., Corso, N. K., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01116-2 · Cited by 51
Alzheimer’s disease: a mini-review for the clinician
Madnani, R. S. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1178588 · Cited by 56
A systematic review and methodological analysis of EEG-based biomarkers of Alzheimer's disease
Modir, A., Shamekhi, S., & Ghaderyan, P. (2023) · Measurement · doi:10.1016/j.measurement.2023.113274 · Cited by 52
Emerging ocular biomarkers of Alzheimer disease
van Wijngaarden, P., Hadoux, X., Alwan, M., Keel, S., & Dirani, M. (2016) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12872 · Cited by 51
Age-accelerated cognitive decline in asymptomatic adults with CSF β-amyloid
Clark, L. R., Berman, S. E., Norton, D., Koscik, R. L., Jonaitis, E. M., Blennow, K., Bendlin, B. B., Asthana, S., Johnson, S. C., Zetterberg, H., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005291 · Cited by 53
Self-citationHolczer, A., Németh, V. L., Vékony, T., Vécsei, L., Klivènyi, P., & Must, A. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.00179 · Cited by 56
Zheng, F., Li, Y., Zhang, F., Sun, Y., Zheng, C., Luo, Z., Wang, Y.-L., Aschner, M., Zheng, H., Lin, L., et al. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.126378 · Cited by 51
Quantitative MRI to understand Alzheimer's disease pathophysiology
Bozzali, M., Serra, L., & Cercignani, M. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000345 · Cited by 51
Gu, L., Chen, J., Gao, L., Shu, H., Wang, Z., Liu, D., Yan, Y., Li, S., & Zhang, Z. (2017) · Clinical Neurophysiology · doi:10.1016/j.clinph.2017.10.030 · Cited by 51
MR-guided delivery of AAV2-BDNF into the entorhinal cortex of non-human primates
Nagahara, A. H., Wilson, B. R., Ivasyk, I., Kovács, I., Rawalji, S., Bringas, J. R., Pivirotto, P., Sebastián, W. S., Samaranch, L., Bankiewicz, K. S., et al. (2018) · Gene Therapy · doi:10.1038/s41434-018-0010-2 · Cited by 52
Kuhn, E., Moulinet, I., Perrotin, A., La Joie, R., Landeau, B., Tomadesso, C., Bejanin, A., Sherif, S., De La Sayette, V., Desgranges, B., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0514-z · Cited by 51
Peripheral blood DNA methylation differences in twin pairs discordant for Alzheimer’s disease
Konki, M., Malonzo, M., Karlsson, I., Lindgrén, N., Ghimire, B. R., Smolander, J., Scheinin, N. M., Ollikainen, M., Laiho, A., Elo, L. L., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0729-7 · Cited by 51
Lupton, M. K., Robinson, G. A., Adam, R. J., Rose, S., Byrne, G. J., Salvado, O., Pachana, N. A., Almeida, O. P., McAloney, K., Gordon, S. D., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102527 · Cited by 49
Hampel, H. J., Vergallo, A., Caraci, F., Cuello, A. C., Lemercier, P., Vellas, B. J., Giudici, K. V., Baldacci, F., Hänisch, B., Haberkamp, M., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108081 · Cited by 52
Self-citationZinc Therapy in Early Alzheimer’s Disease: Safety and Potential Therapeutic Efficacy
Squitti, R., Pal, A., Picozza, M., Avan, A., Ventriglia, M., Rongioletti, M. C. A., & Hoogenraad, T. U. (2020) · Biomolecules · doi:10.3390/biom10081164 · Cited by 62
Alzheimer disease and neuroplasticity
Koch, G., & Spampinato, D. A. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00027-8 · Cited by 50
Prospective biomarkers of Alzheimer’s disease: A systematic review and meta-analysis
Li, R., Ma, Y., Tan, L., & Yu, J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101699 · Cited by 54
Baumann, B., Wöehrer, A., Ricken, G., Augustin, M., Mitter, C., Pircher, M., Kovács, G. G., & Hitzenberger, C. K. F. (2017) · Scientific Reports · doi:10.1038/srep43477 · Cited by 49
Foster, C. M., Kennedy, K. M., Horn, M. M., Hoagey, D. A., & Rodrigue, K. M. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.10.068 · Cited by 49
Smedinga, M., Tromp, K., Schermer, M., & Richard, E. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180638 · Cited by 50
Petralia, M. C., Battaglia, G., Bruno, V., Pennisi, M., Mangano, K., Lombardo, S. D., Fagone, P., Cavalli, E., Saraceno, A., Nicoletti, F., et al. (2020) · Molecules · doi:10.3390/molecules25020291 · Cited by 50
BACE1 controls synaptic function through modulating release of synaptic vesicles
Das, B., Singh, N., Yao, A. Y., Zhou, J., He, W., Hu, X., & Yan, R. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01166-2 · Cited by 49
Robust EEG Based Biomarkers to Detect Alzheimer’s Disease
Al-Nuaimi, A. H. H., Blūma, M., Al-Juboori, S., Eke, C. S., Jammeh, E., Sun, L., & Ifeachor, E. (2021) · Brain Sciences · doi:10.3390/brainsci11081026 · Cited by 49
Bartlett, L., Doherty, K., Farrow, M., Kim, S., Hill, E., King, A. E., Alty, J., Eccleston, C. E. A., Kitsos, A., Bindoff, A. D., et al. (2021) · JMIR Research Protocols · doi:10.2196/34688 · Cited by 48
Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches
Gholami, A. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137532 · Cited by 52
Garcez, M. L., Jacobs, K. R., & Guillemin, G. J. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00057-3 · Cited by 51
Mitochondrial dysfunction in Alzheimer’s disease - a proteomics perspective
Abyadeh, M., Gupta, V., Chitranshi, N., Gupta, V., Wu, Y., Saks, D., Wall, R. V., Fitzhenry, M. J., Basavarajappa, D. K., You, Y., et al. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1918550 · Cited by 51
Behavioral and neuropsychiatric disorders in Alzheimer's disease
Cortés, N., Andrade, V., & Maccioni, R. B. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180005 · Cited by 57
van der Schaar, J., Visser, L. N. C., Ket, J. C. F., Groot, C., Pijnenburg, Y. A. L., Scheltens, P., Bredenoord, A. L., van den Hoven, M., & van der Flier, W. M. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13410 · Cited by 48
Self-citationRabin, J. S., Perea, R. D., Buckley, R. F., Neal, T. E., Buckner, R. L., Johnson, K. A., Sperling, R. A., & Hedden, T. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy031 · Cited by 53
Self-citationLuo, Y.-P., Yang, W., Li, N., Yang, X., Zhu, B.-L., Wang, C., Hou, W.-S., Wang, X., Wen, H., & Tian, X.-L. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00134 · Cited by 42
Hickman, R. A., Flowers, X. E., & Wısnıewskı, T. (2020) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-020-01063-1 · Cited by 48
Overview of therapeutic targets in management of dementia
Malik, R., Kalra, S., Bhatia, S., Al‐Harrasi, A., Singh, G., Mohan, S., Makeen, H. A., Albratty, M., Meraya, A. M., Bahar, B., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113168 · Cited by 51
Robbins, R., Weaver, M. D., Barger, L. K., Wang, W., Quan, S. F., & Czeisler, C. A. (2021) · Journal of Sleep Research · doi:10.1111/jsr.13395 · Cited by 52
Filardi, M., Barone, R., Bramato, G., Nigro, S. L., Tafuri, B., Frisullo, M. E., Zecca, C., Tortelli, R., & Logroscino, G. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.833087 · Cited by 49
Barber, K., Mendonca, P., & Soliman, K. F. A. (2023) · Brain Sciences · doi:10.3390/brainsci13010145 · Cited by 51
Choroid Plexus Volume, Amyloid Burden, and Cognition in the Alzheimer’s Disease Continuum
Jeong, S. H., Park, C. J., Cha, J., Kim, S.-Y., Lee, S., Kim, Y. J., Sohn, Y. H., Chung, S. J., & Lee, P. H. (2024) · Aging and Disease · doi:10.14336/ad.2024.0118 · Cited by 49
Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities
Parent, M. J., Zimmer, E. R., Shin, M., Kang, M. S., Fonov, V., Mathieu, A. P., Aliaga, A., Kostikov, A. P., Carmo, S. D., Dea, D., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1346-17.2017 · Cited by 51
Self-citationWimo, A. B., Handels, R. L. H., Winblad, B. G., Black, C. M., Johansson, G., Salomonsson, S., Eriksdotter, M., & Khandker, R. K. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191055 · Cited by 46
Tang, L., Wu, X., Liu, H., Wu, F., Song, R., Zhang, W., Guo, D., Feng, J., & Li, C. (2021) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27689 · Cited by 45
Chaudhari, V., Bagwe‐Parab, S., Buttar, H. S., Gupta, S., Vora, A., & Kaur, G. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00634-7 · Cited by 47
Martínez-Dubarbie, F., Guerra-Ruiz, A., López-García, S., Lage, C., Fernández-Matarrubia, M., Infante, J., Pozueta-Cantudo, A., García-Martínez, M., Corrales-Pardo, A., Bravo, M., et al. (2023) · Alzheimer's Research & Therapy · doi:10.1186/s13195-023-01319-1 · Cited by 47
Racine, A., Brickhouse, M., Wolk, D., & Dickerson, B. (2018) · Alzheimer's & Dementia · doi:10.1016/j.dadm.2018.02.007 · Cited by 48
Alterations in Dynamic Functional Connectivity in Individuals With Subjective Cognitive Decline
Chen, Q., Lu, J., Zhang, X., Sun, Y., Chen, W., Li, X., Zhang, W., Zhao, Q., & Zhang, B. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.646017 · Cited by 46
Jiang, J., Wang, M., Alberts, I., Sun, X., Li, T., Rominger, A., Zuo, C., Han, Y., Shi, K., & Initiative, A. D. N. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05687-y · Cited by 46
Shou, J., & Shaw, P. (2022) · Cells · doi:10.3390/cells11050796 · Cited by 48
Conklin, B., Conley, B. M., Hou, Y., Chen, M., & Lee, K.-B. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114636 · Cited by 45
Aggregation-induced emission: An illuminator in the brain
Duo, Y., Yang, Y., Xu, T., Zhou, R., Wang, R., Luo, G., & Tang, B. Z. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215070 · Cited by 44
Mayer, G., Frohnhofen, H., Jokisch, M., Hermann, D. M., & Gronewold, J. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1372326 · Cited by 47
Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife
Racine, A. M., Koscik, R. L., Berman, S. E., Nicholas, C. R. N., Clark, L. R., Okonkwo, O. C., Rowley, H. A., Asthana, S., Bendlin, B. B., Blennow, K., et al. (2016) · Brain · doi:10.1093/brain/aww142 · Cited by 46
Self-citationSole, A. D. (2016) · Functional Neurology · doi:10.11138/fneur/2016.31.4.205 · Cited by 49
d’Orsi, E., Xavier, A. J., Rafnsson, S. B., Steptoe, A., Hogervorst, E., & Orrell, M. W. (2017) · Aging & Mental Health · doi:10.1080/13607863.2017.1360840 · Cited by 51
Walters, M., Sterling, J. L., Quinn, C. G., Ganzer, C. A., Osorio, R. S., Andrews, R. D., Matthews, D. C., Vallabhajosula, S., de Leon, M. J., Isaacson, R., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-023664 · Cited by 45
Calderón‐Garcidueñas, L., González-Maciel, A., Kulesza, R. J., González‐González, L. O., Reynoso-Robles, R., Mukherjee, P. S., & Torres‐Jardón, R. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190331 · Cited by 46
Amyloid PET imaging in clinical practice
Kolanko, M., Win, Z., Loreto, F., Patel, N., Carswell, C. J., Gontsarova, A., Perry, R. J., & Malhotra, P. (2020) · Practical Neurology · doi:10.1136/practneurol-2019-002468 · Cited by 47
Kok, F. K., van Leerdam, S., & de Lange, E. C. M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-210607 · Cited by 46
Mehak, S. F., Shivakumar, A. B., Kumari, S., Muralidharan, B., & Gangadharan, G. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104628 · Cited by 45
TMS-EEG perturbation biomarkers for Alzheimer’s disease patients classification
Tăuţan, A.-M., Casula, E. P., Pellicciari, M. C., Borghi, I., Maiella, M., Bonnı̀, S., Minei, M., Assogna, M., Palmisano, A., Smeralda, C. L., et al. (2023) · Scientific Reports · doi:10.1038/s41598-022-22978-4 · Cited by 44
Molina‐Henry, D. P., Raman, R., Liu, A., Langford, O., Johnson, K. A., Shum, L. K., Glover, C. M., Dhadda, S., Irizarry, M. C., Jimenez‐Maggiora, G. A., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13803 · Cited by 44
Self-citationArnerić, S. P., Batrla‐Utermann, R., Beckett, L. A., Bittner, T., Blennow, K., Carter, L., Dean, R. A., Engelborghs, S., Genius, J., Gordon, M. F., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160573 · Cited by 44
Self-citationAhmad, S., Bannister, C. A., van der Lee, S. J., Vojinović, D., Adams, H. H. H., Ramírez, A., Escott‐Price, V., Sims, R., Baker, E. A., Williams, J. H., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.01.005 · Cited by 46
Han, S., Park, J., Byun, M. S., Yi, D., Lee, J. H., Lee, D. Y., & Mook‐Jung, I. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.09.001 · Cited by 44
Wang, Z., Qiao, K., Chen, G., Sui, D., Dong, H.-M., Wang, Y., Li, H., Lu, J., Zuo, X., & Han, Y. (2019) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2019.00026 · Cited by 43
Lue, L., Pai, M., Chen, T., Hu, C., Huang, L.-K., Lin, W., Wu, C., Jeng, J.-S., Blennow, K., Sabbagh, M. N., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00222 · Cited by 46
Self-citationGrässler, B., Herold, F., Dordevic, M., Gujar, T. A., Darius, S., Böckelmann, I., Müller, N. G., & Hökelmann, A. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046879 · Cited by 42
Frank, B. E., Ally, M., Brekke, B., Zetterberg, H., Blennow, K., Sugarman, M. A., Ashton, N. J., Karikari, T. K., Tripodis, Y., Martin, B. M., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12508 · Cited by 40
Self-citationChu, C., Hung, C., Ponnusamy, V. K., Chen, K.-C., & Chen, N.-C. (2022) · Nutrients · doi:10.3390/nu14061159 · Cited by 45
Monoclonal Antibody Therapy in Alzheimer’s Disease
Neațu, M., Covaliu, A., Ioniță, I., Jugurt, A., Davidescu, E. I., & Popescu, B. O. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics16010060 · Cited by 46
Xiong, Y., Tvedt, J., Åkerstedt, T., Cadar, D., & Wang, H. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115760 · Cited by 47
Sethi, P., Bhaskar, R., Singh, D. K. K., Gupta, S., Han, S. S., Avinash, D., Abomughaid, M. M., Koul, A., Rani, B., Ghosh, S., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102411 · Cited by 44
Metadata
- Authors
- Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., Broich, K., Cavedo, E., Crutch, S., Dartigues, J., Duyckaerts, C., Epelbaum, S., Frisoni, G. B., Gauthier, S., Genthon, R., Gouw, A. A., Habert, M., Holtzman, D. M., Kivipelto, M., Lista, S., Molinuevo, J., O'Bryant, S. E., Rabinovici, G. D., Rowe, C., Salloway, S., Schneider, L. S., Sperling, R., Teichmann, M., Carrillo, M. C., Cummings, J., Jack, C. R., & Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer's Association on “The Preclinical State of AD”; July 23, 2. W. D.
- Affiliations
- Sorbonne Université (FR)
- University of British Columbia (CA)
- Amsterdam Neuroscience (NL)
- University of Southern California (US)
- Université Toulouse III - Paul Sabatier (FR)
- Institut du Cerveau (FR)
- Centre National de la Recherche Scientifique (FR)
- Institute for Integrative and Experimental Genomics (DE)
- Sahlgrenska University Hospital (SE)
- Federal Institute for Drugs and Medical Devices (DE)
- Centro San Giovanni di Dio Fatebenefratelli (IT)
- UCL Queen Square Institute of Neurology (GB)
- Université de Bordeaux (FR)
- University of Geneva (CH)
- Douglas Mental Health University Institute (CA)
- Fondation pour la Recherche sur Alzheimer Hôpital Pitié‐Salpêtrière Paris France
- Washington University in St. Louis (US)
- Karolinska University Hospital (SE)
- AXA Research Fund (FR)
- Alzheimer's Disease and Other Cognitive Disorders Unit, Hospital Clínic Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain
- Center for Alzheimer's & Neurodegenerative Disease Research University of North Texas Health Science Center TX USA
- University of California, San Francisco (US)
- The University of Melbourne (AU)
- Brown University (US)
- Brigham and Women's Hospital (US)
- The Alzheimer's Association Division of Medical & Scientific Relations Chicago USA
- Cleveland Clinic (US)
- Department of Radiology Mayo Clinic Rochester MN USA
- Corresponding author
- Dubois, Bruno
- ORCID
- Dubois, Bruno
- Hampel, Harald
- Feldman, Howard H.
- Scheltens, Philip
- Andrieu, Sandrine
- Bakardjian, Hovagim
- Benali, Habib
- Bertram, Lars
- Blennow, Kaj
- Broich, Karl
- Cavedo, Enrica
- Crutch, Sebastian
- Dartigues, Jean‐François
- Duyckaerts, Charles
- Epelbaum, Stéphane
- Frisoni, Giovanni B.
- Gauthier, Serge
- Gouw, Alida A.
- Habert, Marie‐Odile
- Holtzman, David M.
- Kivipelto, Miia
- Lista, Simone
- Rabinovici, Gil D.
- Rowe, Christopher
- Salloway, Stephen
- Schneider, Lon S.
- Sperling, Reisa
- Teichmann, Marc
- Cummings, Jeffrey
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2016-03
- Volume
- 12
- Issue
- 3
- Pages
- 292-323
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- PMC
- PMC6417794
- OpenAlex
- W2309442902
- Cited by
- 1,925
- References
- 298
- Citations by year
- 2026: 115 · 2025: 176 · 2024: 244 · 2023: 245 · 2022: 247 · 2021: 244 · 2020: 176 · 2019: 157 · 2018: 161 · 2017: 112 · 2016: 47
- FWCI
- 22.78
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Alzheimer s & Dementia (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- AXA Research Fund
- National Institute on Aging
- Alzheimer's Association
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- preclinical Alzheimer's disease, Alzheimer's disease continuum
- MeSH terms
- Alzheimer Disease, Animals, Brain, Humans, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
